News
Blog
19.11.2026

From pandemic preparedness to lasting partnerships

‍Researchers, public health officials and vaccine developers need to work together long before a health crisis starts. Marissa Gripenberg explains why these partnerships matter just as much between pandemics.

‍

We don’t know when the next pandemic will hit. But we can make sure we’re prepared.

‍

That means more than having a plan. Those involved in research, treating patients and developing vaccines need to make those connections and learn how to work together before a crisis starts.

‍

BE READY is a European Partnership for Pandemic Preparedness. Launched by the European Commission in February 2026, BE READY coordinates research across 81organizations in 27 countries to anticipate and respond to infectious disease outbreaks. How to build cooperation was one of the questions discussed at the BE READY workshop with private sector representatives in Madrid on 16 and 17 November. Marissa Gripenberg, Senior R&D Specialist at FVR – Finnish Vaccine Research, participated in a panel discussion on what researchers and companies can bring to this work.

‍

For Gripenberg, these partnerships also matter beyond preparing for a crisis. “Partnerships between the private sector and BE READY must extend beyond pandemic preparedness and become sustained, ongoing collaborations to strengthen Europe’s global competitiveness in clinical trials.”

‍

Cooperation needs to start before a crisis

Recentpandemics have shown why this matters. Once a crisis has begun, there’s littletime to build a new research partnership.

Research teams, clinics and healthcare professionals need practice working together. For vaccine developers, having partners already in place makes it easier to turn are search question into a study involving people.

FVR has valuableexperience to share. As part of its regular work, it runs clinical vaccinestudies through its network of study clinics together with public sectorpartners and international vaccine developers.

‍

Different partners bring different strengths

Preparing fora pandemic takes cooperation. No single group can do it alone.

Public bodiesand research networks bring scientific knowledge, health data and links withhealthcare services and potential study participants. Companies bringexperience in vaccine development, new technologies and funding.

Workingtogether can help them get studies started earlier. In Madrid, researchers andcompanies weren’t just discussing the next pandemic, but also how to worktogether in their everyday research.

‍

Staying ready between pandemics

Europe already has seasoned researchers, clinics and research networks. This landscape is however fragmented and the challenge is to keep them working together, even across national borders.

When a new health threat emerges, people and clinics need to be ready to start studies without having to find partners first. BE READY aims to make this possible by building a European research network that stays active between pandemics.

‍

The workdoesn’t stop in Madrid. Researchers and vaccine manufacturers can build lastingpartnerships by working together on studies, but this takes time and needs tocontinue beyond workshops and meetings. That work helps them prepare for themoment when those partnerships are needed most.

‍

Want to speak to an expert?
Your one-stop-shop for all inquiries and feasibilities is: feasibility@fvr.fi. However, if you'd prefer to speak to an expert or have any questions, please get in touch with Arto or Ilona.
Medical & scientific queries
Arto Palmu
Chief Scientific Officer
arto.palmu@fvr.fi
Commercial queries
Ilona Schmidt
Head of Customer Relations
ilona.schmidt@fvr.fi